Qualified Institutional Placement

September 16, 2026 BSE Limited National Stock Exchange of India Limited Department of Corporate Services Listing Department, Exchange Plaza, Floor 25, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai 400 001 Mumbai – 400 051 Scrip Code No: 542665 Company Symbol: NEOGEN Debt Segment Code: 977028 Re: Qualified institutions placement of equity shares of face value of ₹10 each (the “Equity Shares”) by Neogen Chemicals Limited (the “Company”) (the “QIP” or “Issue”) in terms of the provisions of Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (“SEBI ICDR Regulations”), and Section 42 and Section 62 of the Companies Act, 2013, as amended (the “Companies Act”) read with the rules issued thereunder. Sub: Outcome of the meeting of the Fund-Raising Committee held on September 16, 2026 Dear Sir/Madam, Pursuant to the approval of the Board of Directors of the Company (the “Board”) at its meeting held on July 24, 2026, and approval of the shareholders of the Company by way of a special resolution passed on August 21, 2026 (the “Shareholders’ Approval”), and our letter dated September 10, 2026, intimating you about the outcome of the meeting of the Fund-Raising Committee in respect of the QIP, we wish to further inform you that in respect of the QIP, the Fund-Raising Committee (the “Committee”), of the Company has, at its meeting today, i.e. September 16, 2026, which commenced at 9:30 p.m. and concluded at 9:51 p.m. inter alia, considered and approved the following resolutions: (i) approved and declared the closure of issue period for the QIP today, i.e. September 16, 2026, pursuant to the receipt of application forms for an aggregate of 26,60,753 fully paid-up Equity Shares of the Company and the funds in the escrow account from eligible qualified institutional buyers in accordance with the terms of the Issue, which opened on September 10, 2026; (ii) determined and approved the issue price in consultation with lead managers appointed for the Issue (the “LMs”), for 26,60,753 Equity Shares of a face value of ₹ 10 each to be allotted to eligible QIBs at a price of ₹ 2,255 per Equity Share, including a premium of ₹2,245 per Equity Share. (iii) approved and adopted the placement document dated September 16, 2026 in connection with the QIP. (iv) approved and finalized the confirmation of allocation note to be sent to eligible qualified institutional buyers, intimating them of allocation of Equity Shares pursuant to the QIP; and In this relation we will be filing the placement document dated September 16, 2026, with your office. The QIP was opened on September 10, 2026, and the same was intimated to you pursuant to our letter dated September 10, 2026. Copy of the placement document and this intimation is also being made available on the website of our Company at https://neogenchem.com/announcements/ under the Issue of Securities Tab. Registered Office: 1002, Dev Corpora, Cadbury Junction, E: sales@neogenchem.com T: +91 22 2549 7300 Eastern Express Highway, Thane (W) 400 601, India. W: www.neogenchem.com F: +91 22 2549 7399 CIN No. L24200MH1989PLC050919 Kindly take the above information on your records Thanking you, For Neogen Chemicals Limited Unnati Kanani Company Secretary and Compliance Officer Mem. No. A35131 Place: Thane Registered Office: 1002, Dev Corpora, Cadbury Junction, E: sales@neogenchem.com T: +91 22 2549 7300 Eastern Express Highway, Thane (W) 400 601, India. W: www.neogenchem.com F: +91 22 2549 7399 CIN No. L24200MH1989PLC050919